Compare ARK Genomic Revolution ETF (ARKG) vs CAVA Group Inc (CAVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs CAVA Group Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.84, while CAVA Group Inc trades at $72.77 (market cap $8.41B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, CAVA Group Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CAVA | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $97.39 |
52-Week Low | $23.09 | $43.59 |
Market Cap | — | $8.41B |
Enterprise Value | — | $8.50B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CAVA Group trades at $72.18, up 5.84% in the last session, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported Q1 2026 EPS of $0.20, beating expectations, and revenue growth to $1.18 billion in 2025. Analyst sentiment remains strongly positive with 72% buy ratings and a consensus price target of $94.19, though high valuation multiples like a P/E of 138.81 signal premium pricing. Recent news highlights expansion and innovation efforts.
Outlook: CAVA's growth trajectory and analyst optimism support upside potential, but elevated valuations and margin pressures pose risks. Investment opportunity lies in continued expansion and market share gains, while risks include competitive intensity and execution challenges in scaling operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About CAVA Group Inc
CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.
Read more on CAVA →
